NuAcRes

NuAcRes

Pre-clinical
Munich, GermanyFounded 2016nuacres.com

Develops antibody-based therapeutics targeting cancer and autoimmune diseases.

Founded
2016
Focus
AntibodiesOncology

About

Develops antibody-based therapeutics targeting cancer and autoimmune diseases.

Funding History

2

Total raised: $6.4M

Seed$3.2MHigh-Tech GründerfondsMar 15, 2023
Seed$3.2MHigh-Tech GründerfondsMar 15, 2022

Company Info

TypePrivate
Founded2016
LocationMunich, Germany
StagePre-clinical
SIMILAR COMPANIES
300Microns
300Microns
Pre-clinical · Munich
BetaSense
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Mireca Medicines
Pre-clinical · Munich
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile